Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem R P Agema

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Heart Journal|November 8, 2002
A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication biasWillem R P Agema, J Wouter Jukema, Aeilko H Zwinderman, et al.
Drug Safety - Case Reports|August 9, 2018
Metoclopramide: A Safe Alternative to Domperidone? A Case Report on Severe Cardiac Adverse Effects in an Older PatientLaura C Sijtsma, Carolina J P W Keijsers, Angèle P M Kerckhoffs, et al.
Geroscience|September 5, 2025
Short communication and clear content of geriatric recommendations matter! Evaluation of geriatric recommendation acceptance in patients aged ≥ 85 years hospitalized for cardiac conditionsRenee C M A Raijmann, Huiberdina L Koek, Marielle H Emmelot-Vonk, et al.
Thrombosis and Haemostasis|April 30, 2004
Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosisWillem R P Agema, J Wouter Jukema, Moniek P M de Maat, et al.
Circulation|May 14, 2003
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular eventsS Matthijs Boekholdt, Willem R P Agema, Ron J G Peters, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 31, 2023
Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and overRenee C M A Raijmann, Huiberdina L Koek, Marielle H Emmelot-Vonk, et al.
Stroke|September 2, 2006
Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or strokeSebastiaan F T M de Bruijn, Willem R P Agema, Gert Jan Lammers, et al.
European Journal of Heart Failure|July 26, 2013
Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trialWillemien L Verloop, Martine M A Beeftink, Alex Nap, et al.
Clinical Science (London, England : 1979)|April 8, 2004
An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in menWillem R P Agema, Moniek P M de Maat, Aeilko H Zwinderman, et al.
European Heart Journal|July 3, 2004
Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent eraWillem R P Agema, Pascalle S Monraats, Aeilko H Zwinderman, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Heart Journal|November 8, 2002
A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: evidence for publication biasWillem R P Agema, J Wouter Jukema, Aeilko H Zwinderman, et al.
Drug Safety - Case Reports|August 9, 2018
Metoclopramide: A Safe Alternative to Domperidone? A Case Report on Severe Cardiac Adverse Effects in an Older PatientLaura C Sijtsma, Carolina J P W Keijsers, Angèle P M Kerckhoffs, et al.
Geroscience|September 5, 2025
Short communication and clear content of geriatric recommendations matter! Evaluation of geriatric recommendation acceptance in patients aged ≥ 85 years hospitalized for cardiac conditionsRenee C M A Raijmann, Huiberdina L Koek, Marielle H Emmelot-Vonk, et al.
Thrombosis and Haemostasis|April 30, 2004
Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosisWillem R P Agema, J Wouter Jukema, Moniek P M de Maat, et al.
Circulation|May 14, 2003
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular eventsS Matthijs Boekholdt, Willem R P Agema, Ron J G Peters, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|August 31, 2023
Impact of geriatric co-management on outcomes in hospitalised cardiology patients aged 85 and overRenee C M A Raijmann, Huiberdina L Koek, Marielle H Emmelot-Vonk, et al.
Stroke|September 2, 2006
Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or strokeSebastiaan F T M de Bruijn, Willem R P Agema, Gert Jan Lammers, et al.
European Journal of Heart Failure|July 26, 2013
Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trialWillemien L Verloop, Martine M A Beeftink, Alex Nap, et al.
Clinical Science (London, England : 1979)|April 8, 2004
An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in menWillem R P Agema, Moniek P M de Maat, Aeilko H Zwinderman, et al.
European Heart Journal|July 3, 2004
Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent eraWillem R P Agema, Pascalle S Monraats, Aeilko H Zwinderman, et al.
Pageof 2